JPS61154571A - 単針式膜血漿分離装置 - Google Patents

Info

Publication number

JPS61154571A

JPS61154571A JP59278528A JP27852884A JPS61154571A JP S61154571 A JPS61154571 A JP S61154571A JP 59278528 A JP59278528 A JP 59278528A JP 27852884 A JP27852884 A JP 27852884A JP S61154571 A JPS61154571 A JP S61154571A

Authority

JP

Japan

Prior art keywords

blood

plasma

pump

line

anticoagulant

Prior art date

1984-12-26

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000012528 membrane Substances 0.000 title claims description 36
• 238000000926 separation method Methods 0.000 title claims description 25
• 210000002966 serum Anatomy 0.000 title 1
• 210000004369 blood Anatomy 0.000 claims description 78
• 239000008280 blood Substances 0.000 claims description 78
• 210000003743 erythrocyte Anatomy 0.000 claims description 39
• 239000003146 anticoagulant agent Substances 0.000 claims description 30
• 229940127219 anticoagulant drug Drugs 0.000 claims description 30
• 238000001514 detection method Methods 0.000 claims description 22
• 239000012141 concentrate Substances 0.000 claims description 20
• 230000036770 blood supply Effects 0.000 claims description 15
• 239000007788 liquid Substances 0.000 claims description 7
• 238000011144 upstream manufacturing Methods 0.000 claims description 6
• 230000004087 circulation Effects 0.000 claims description 5
• 210000004204 blood vessel Anatomy 0.000 claims description 4
• 210000002381 plasma Anatomy 0.000 description 65
• 230000017531 blood circulation Effects 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 5
• 238000000034 method Methods 0.000 description 5
• 239000012510 hollow fiber Substances 0.000 description 3
• 210000000601 blood cell Anatomy 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 229920002284 Cellulose triacetate Polymers 0.000 description 1
• 206010018910 Haemolysis Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000000701 coagulant Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 230000008588 hemolysis Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1